blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4035657

EP4035657 - DRUG COMPOSITION CONTAINING ABIRATERONE ACETATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  01.07.2022
Database last updated on 16.11.2024
FormerThe international publication has been made
Status updated on  03.04.2021
Most recent event   Tooltip18.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Hunan Huize Bio-Pharmaceutical Co., Ltd
Floor 4, Building A-4, Jinrui Lugu Sci&Tech Park
No. 28 Lutian Road
New&High-Tech Industrial Development Zone
Changsha, Hunan 410205 / CN
[2022/31]
Inventor(s)01 / YI, Mulin
Floor 4, Building A-4, Jinrui Lugu Sci&Tech Park
No. 28 Lutian Road, New&High-Tech Industrial
Development Zone
Changsha, Hunan 410205 / CN
 [2022/31]
Representative(s)Zwicker, Jörk
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2022/31]
Application number, filing date20867834.218.05.2020
[2022/31]
WO2020CN90866
Priority number, dateCN20191091663626.09.2019         Original published format: CN201910916636
[2022/31]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021057042
Date:01.04.2021
Language:ZH
[2021/13]
Type: A1 Application with search report 
No.:EP4035657
Date:03.08.2022
Language:EN
[2022/31]
Search report(s)International search report - published on:CN01.04.2021
(Supplementary) European search report - dispatched on:EP19.10.2022
ClassificationIPC:A61K9/107, A61K9/48, A61K47/44, A61K47/14, A61K47/10, A61K31/58, A61P13/08, A61P35/00, A61K9/08, // A61K47/26
[2022/46]
CPC:
A61K9/1075 (EP,CN); A61K31/58 (EP,CN,US); A61K47/10 (EP,CN);
A61K47/14 (EP,CN); A61K47/44 (EP,CN,US); A61K9/08 (EP);
A61K9/107 (US); A61K9/4808 (CN); A61K9/4858 (EP,CN);
A61P13/08 (EP); A61P35/00 (EP,CN); A61P35/04 (CN);
A61K47/26 (EP) (-)
Former IPC [2022/31]A61K9/107, A61K9/48, A61K47/44, A61K47/14, A61K47/10, A61K31/58, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/31]
TitleGerman:WIRKSTOFFZUSAMMENSETZUNG MIT ABIRATERONACETAT UND VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG[2022/31]
English:DRUG COMPOSITION CONTAINING ABIRATERONE ACETATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF[2022/31]
French:COMPOSITION DE MÉDICAMENT CONTENANT DE L'ACÉTATE D'ABIRATÉRONE, SON PROCÉDÉ DE PRÉPARATION ET SON APPLICATION[2022/31]
Entry into regional phase10.02.2022Translation filed 
10.02.2022National basic fee paid 
10.02.2022Search fee paid 
10.02.2022Designation fee(s) paid 
10.02.2022Examination fee paid 
Examination procedure10.02.2022Examination requested  [2022/31]
20.01.2023Amendment by applicant (claims and/or description)
20.01.2023Date on which the examining division has become responsible
Fees paidRenewal fee
30.03.2022Renewal fee patent year 03
15.03.2023Renewal fee patent year 04
18.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2014009434  (SANDOZ AG [CH], et al) [I] 1-11 * page 22, paragraph L - page 24 * * claim -; table 4 * * page 18 * * page 1 - page 2 *;
 [XI]CN105055314  (HANGZHOU ANDE TECHNOLOGY CO LTD) [X] 1-3,7,8 * example -; claim - * * paragraph [0003] - paragraph [0004] * [I] 4-6;
 [I]CN105535979  (LI SUHUA) [I] 1 * claims 6, 7 *;
 [A]  - POUTON C W, "FORMULATION OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM , NL, (19970414), vol. 25, no. 1, doi:10.1016/S0169-409X(96)00490-5, ISSN 0169-409X, pages 47 - 58, XP000866526 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0169-409X(96)00490-5
International search[X]CN105535979  (LI SUHUA) [X] 1-6, 8 * abstract, claims 1-10, description paragraphs 0002, 0039-0040, embodiment 7 *;
 [Y]CN105535979  (LI SUHUA) [Y] 7, 9-10 * abstract, claims 1-10, description paragraphs 0002, 0039-0040, embodiment 7 *;
 [X]CN106692051  (NANJING NORATE PHARMACEUTICAL TECH CO LTD) [X] 1-8, 10 * claims 1-9, description paragraphs 0002, 0009 *;
 [Y]CN106692051  (NANJING NORATE PHARMACEUTICAL TECH CO LTD) [Y] 9 * claims 1-9, description paragraphs 0002, 0009 *;
 [A]CN106821977  (UNIV FUJIAN MEDICAL) [A] 1-10 * entire document *;
 [A]CN107468650  (ZHENGZHOU TAIFENG PHARMACEUTICAL CO LTD) [A] 1-10* entire document *;
 [PX]CN110538150  (HUNAN RUILIN MEDICINE TECH CO LTD) [PX] 1-10 * entire document *;
 [Y]  - REN, Tong et al., "Clinical progress of abiraterone in the treatment of metastatic prostatic cancer", Chinese Journal of Biochemical and Pharmaceutics, (20161231), vol. 36, no. 7, ISSN 1005-1678, pages 205 - 208+212, XP055795231 [Y] 7, 9-10 * pages 205-208 and 212 *
by applicantCN107278152
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.